People: Eli Lilly and Co (LLY.N)
25 May 2017
Dr. William G. Kaelin Jr., M.D., is Independent Director of the Company. He is a prominent medical researcher and academician. He has extensive experience at Harvard Medical School, a major medical institution, as well as special expertise in oncology—a key component of Lilly's business. He also has deep expertise in basic science, including mechanisms of drug action, and experience with pharmaceutical discovery research.
|Total Annual Compensation, USD||134,000|
|Restricted Stock Awards, USD||160,000|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||20,500|
|Fiscal Year Total, USD||314,500|